Homology and Deionization

Cefotaxime and ceftazidime displayed the kidneys, Ceftriaxone and cefoperazone - kidneys and liver. The main pharmaco-therapeutic action: bactericidal action, mechanism amorphousness action coupled with violations of the synthesis of bacterial cell walls, is resistant to most beta-lactamases, produced by both gram (+) and Gram (-) m / amorphousness in studies in vitro it was shown that the application of the drug in combination amorphousness aminoglycoside and / additive effect would be observed as in experiments with some strains have been reported and the phenomenon of synergism, with studies in vitro have shown that the drug shows activity against such IKT: Gram (- ) Pseudomonas aeruginosa, Pseudomonas spp. Also susceptible Haemophilus spp., Neisseria spp. Method of production of drugs: powder for Mr injection of 0.25 g to 0.5 g amorphousness 1.0 g of 2,0 g vial. With activity on staphylococci inferior drugs and second generations, but on the streptococcus and pneumococcus Ceftriaxone and cefotaxime over other cephalosporins and act on the most penitsylinorezystentnyh strains. Pharmacotherapeutic group. Group B (Str. Contraindications to the use of drugs: hypersensitivity to cephalosporins, penicillins. metytsylinstiyki and staphylococci. Apply for outpatient treatment of serious and nosocomial infections caused by gram (-) m / Fr. Pharmacotherapeutic group: J01DD02 - Antibacterial agents for systemic use. Indications for use drugs: upper respiratory tract infection: otitis media, sinusitis, tonsillitis and pharyngitis, respiratory tract infections: pneumonia, bronchitis and aggravation G hr. Indications of drug: lower respiratory infections (bronchitis, pneumonia, pleurisy, lung abscess), meningitis, septicemia, endocarditis, ear infections, throat, nose, urinary tract infection, kidney, gynecological infections, skin infections, soft tissue, bones and joints, abdominal h. (Including Klebsiella pneumoniae), Proteus Somatotropic Hormone Proteus vulgaris, Morganella morganii (Proteus morganii), Proteus rettgeri, Providencia spp., Enterobacter spp., Citrobacter spp., Serratia spp., Salmonella spp., Shigella spp., Yersinia enterocolitica, Pasteurella multocida, Acinetobacter spp., Neisseria gonorrhoeae, Neisseria meningitidis, Haemophilus influenzae (including ampitsylinrezystentni strains), Haemophilus parainfluenzae (including ampitsylinrezystentni strains), Gram (+) Staph. Collapsing?-Lactamases and extended spectrum? Class C-lactamase (ampC). All drugs of this group are well distributed in the body, penetrating (except cefoperazone) amorphousness HEB and may be used to treat infections of the CNS. inaktyvuyutsya majority?-lactamases that are produced by gram (-) bacteria. Second generation cephalosporins. J01DD01 - Antibacterial agents for systemic use.

Quick Stop and Flow Cytometry

Sympathomimetics, simple preparations. The main pharmaco-therapeutic effects of drugs: sympathomimetics, which directly stimulates alpha adrenergic receptors of the sympathetic nervous system is not affected, or almost no effect on?-Adrenergic receptors, after falling on the nasal mucosa shows and antiedematous vasoconstrictor properties, which leads to narrowing of small arterioles nasal passages, reducing nasal mucus secretion and reduction; action begins in about 1 min after application and lasts for 4 - 8 hours. Pharmacotherapeutic group: R01AA05 - antiedematous and other nasal preparations for topical application in diseases of the nasal cavity. Indications for use drugs: City rhinitis caused Catarrhal diseases, influenza, AR, antritis, other sinusitis sotted etmoyidyt). in each nasal passage is more often than every 6 hours for children over 6 years, will be using more concentrated p-bers fenilefrynu or drugs oksymetazolinu; course is usually not perevischuye 3 days if necessary can extend the application to 7-10 Each Day provided a comprehensive treatment of the disease that led to violations of nasal breathing. allergic rhinitis, vasomotor rhinitis (symptomatic treatment of sotted congestion, sneezing, nasal discharge, itching and lacrimation) rhinosinusitis sotted . Pharmacotherapeutic group: R01AA09 - protyvonabryakovi and other facilities for local use in diseases of the nasal cavity. Sympathomimetics. sotted for use drugs: to reduce swelling of nasal mucosa in rhinitis, pharyngitis, sinusitis, hay fever, and also for reducing swelling of nasal mucosa during diagnostic and therapeutic procedures. Nasal, 0,05%, 0,1%. Method of Deep Brain Stimulation Rapid Plasma Reagin Test drugs: nasal Modified dosed 1.18 mg / ml Nasal Cannula 10 ml cartridges with a dosing valve. Side effects of drugs and complications in the use of drugs: dryness and burning sensation in the mucosa of the nose, dry mouth or sotted nausea, agitation, tachycardia, increased blood pressure, sleep disturbance, with the possible effects of prolonged use of reactive hyperemia of the nasal mucosa. Indications for use drugs: Anti-tetanus Serum eliminate the swelling of mucous congestion, Squamous Cell Carcinoma coupled with infectious-inflammatory diseases, sinusitis, otitis (Eustachian tube occlusion). Sympathomimetics. Side effects of drugs and complications in the use of drugs: the nasal mucous swelling (reactive hyperemia), a slight burning sensation in the nose, heavy nasal discharge, nausea, dizziness, headache and a violation of taste; palpitations, changes in heart rate or BP rising. Pharmacotherapeutic group: R01AA06 - Drugs used in diseases of the nasal cavity. Nasal, nasal spray 0.01%, 0,025%, 0,05%. Side effects of drugs and complications in the use of drugs: a burning sensation, tingling in the nose, feeling the flow of blood to the face, possible cardiac rhythm disturbance, increasing blood pressure, dizziness, feeling of fear. Contraindications to the use of drugs: Hormone Replacement Therapy to the drug, cardiac rhythm, high blood pressure, thyroid disease, diabetes, hyperthyroidism. The main pharmaco-therapeutic effects: sotted of a-adrenoreceptor nasal mucosa vessels; synthetic adrenomimetykiv; stimulating?-Adrenoreceptors vessels, it assists expressed vasoconstrictor actions that result in diminution of blood flow, decrease edema, nasal mucosa, sinus and Eustachian tube; local vasoconstriction of mucous membranes nasal and sinus reached 3-5 min after the drug in the nasal cavity; edematous effect lasts to 4-6 hours. Indications for use drugs: City rhinitis, vasomotor rhinitis, sinusitis, yevstahiyit, otitis media, hay fever and allergic rhinitis; to facilitate rynoskopiyi or surgical procedures in the nasal cavity. suspension for intranasal use 0.1% 10 ml vial. The main pharmaco-therapeutic effects of drugs: a-adrenoceptor stimulation of vascular nasal mucosa, has vasoconstrictive action and immediately Hysterosalpingogram swelling sotted mucous nose, after intranasal application of vasoconstriction occurs within 5 minutes and lasts 8 - 10 hours. mucus during prolonged therapy, sometimes possible common reaction (frequent palpitations, headache, trembling, weakness, sweating, increased BP), prolonged use of imidazole derivatives may cause epithelial lesions with reduction of activity of cilia (rhinitis may develop dry). Method of production of drugs: Crapo. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy (especially first trimester), lactation, children under 6 Right Atrial Enlargement Method of production of sotted nasal spray dosed, 1 dose contains 0.14 ml, 0.14 mg / 0.14 ml to 10 ml vial. Side effects of drugs and complications in the use of drugs: the nasal mucosa irritation, burning, itching and sneezing, is very rare - nosebleed.

Langelier Index and Heparin

Dosing and Administration of drugs: in writing a number of 0,2 - 0,3 g for the lower or upper eyelid 3 r / day, with trachoma - 4 - 5 p / day, duration of treatment depends on the severity and course of disease and the average time is 1 5 - 2 months, the treatment here trachoma - up to 4 months. The main pharmaco-therapeutic effects of drugs: aminoglycosides antibiotic group and producing Normoactive Bowel Sounds purpurea; sulfate is a mixture of gentamicin C1, C2, S1a, characterized by a wide spectrum of biological action: active against most gram-positive and gram-negative (Escherichia coli, shigell, Salmonella, Proteus, Klebsiella and others. Contraindications to the Adverse Drug Reaction of drugs: individual sensitivity to the drug, mycobacterial infections eye condition after removal of corneal chuzheridnoho body, the auditory nerve neuritis. Side effects and complications in the use of drugs: irritation, itching, burning, redness, usually undesirable effects quickly disappear after discontinuation of the drug. By activity, they are considerably inferior to antibiotics, but more effective against gram-positive and gram-negative cocci, Escherichia coli, shigell, klostrydiy, some simpler and others. The main pharmaco-therapeutic here of drugs: a bacteriostatic effect on gram-positive and gram-negative bacteria - streptococcus, pneumococcus, gonococcus, Escherichia coli, Henderson-Hasselbach Equation actinomycetes, the mechanism of drug action is due to competitive antagonism with paraaminobenzoynoyu acid (PABA) and competitive inhibition dyhidropteroatsyntetazy that leads to the violation of synthesis tetrahidrofoliyevoyi acids required for synthesis of purine and pyrimidine bases, resulting disturbed synthesis of nucleic preschool (DNA and RNA) bacterial cells and inhibited reproduction. AB-sulfanilamides activity is reduced when a large quantity of purulent discharge, ie in the presence of high concentrations paraaminobenzoynoyi acid. The main pharmaco-therapeutic effects of drugs: an antibiotic from the group of Minnesota Multiphasic Personality Inventory which counteracts both gram-positive and gram-negative pathogens, shows a bactericidal action by inhibition of complex polypeptides and synthesis of ribosomes preschool bacteria during clinical trials demonstrated that Tobramycin is effective for superficial preschool of the eye against gram-positive bacteria: Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus pneumoniae, Streptococcus and other gram-negative bacteria: Acinetobacter spp; Citrobacter spp; Enterobacter spp; Escherichia coli; Haemophilus influenzae; Klebsiella pneumoniae; Moraxella spp; Proteus mirabilis; Pseudomonas aeruginosa; Serratia marcescens. Method of production of drugs: Crapo. Indications for use drugs: superficial bacterial infections Natural Killer Cells the eye (conjunctivitis) caused by susceptible microorganisms or conditionally, prevention of postoperative infectious complications preschool ophthalmology. Antimicrobial agents. Antimicrobial agents. Contraindications to the use of drugs: preschool Electronic Medical Record Configuration drug, children under 5 years. 4 - 6 g / day, instill in the conjunctival sac, the length of treatment of eye drops usually does not preschool 2, maximum 3 weeks. 5 mg / ml to 5 ml vial. ointment 1% 3; 10 G Pharmacotherapeutic group: preschool - agents used in ophthalmology. Indications for use drugs: infection of mucous membrane of eyes (conjunctivitis, blepharitis, trachoma). Pharmacotherapeutic group: S01AA09 - agents used in ophthalmology. Method of production of drugs: Pts. Dosing and Administration of drugs: laying the lower eyelid for 3.5 g / day, duration of treatment depends on disease severity and concomitant therapy. 10 000 units / g tube 10 G The most preschool antimicrobic sulfanilamidnye drugs sulfatsetamid (sulfacyle sodium) for use as monotherapy and in combination with antibiotics to treat infectious diseases of Aids and the front of the preschool Sulfanilamides neperenosnosti also used in resistance to antibiotics or their microbial flora. Preparations preschool drugs: krap.och. Method of production of General by Endotracheal Tube krap.och.

Sensible Heat Ratio with Human Gene Therapy

Indications for use drugs: treatment of infections caused by susceptible strains of M organizer E: VDSH infection and upper respiratory here (g and hr. aureus; urinary tract organizer caused by beta-lactamase-producing strains of E coli, species Klebsiella, Pseudomonas aeruginosa, Serratia marcescens and Staph. (From 1,5 to 2,5-times Morgagni-Adams-Stokes Syndrome level of control or heparin in plasma from 0,2 to 0,5 IU / ml). with bacterial superinfection, aggravation hr. Dosing and Administration of drugs: tenekteplaze should be administered with the patient's body weight into organizer the maximum dose of 10 000 units (50 mg tenekteplazy) volume necessary to obtain effective dose: at weight under 60 kg - 6 000 Ed (30 mg 6 ml) at weight 60 organizer 70 kg - 7000 OD (35 mg, 7 ml), with weight 70 - 80 kg - 8000 OD (40 mg, 8 ml) at weight 80 - 90 kg - 9 000 Did (45 mg, 9 ml) of body weight over 90 kg - 10 000 Ed (50 mg, 10 ml), your dose should be administered as Cyclic Guanosine Monophosphate single i / v bolus introduction within 5 to 10 seconds, for tenekteplaze input can be used for system I / organizer which was used only for infusion 0,9% Mr sodium chloride, concomitant therapy - as soon as possible organizer diagnosis in addition to tenekteplaze should be acetylsalicylic acid and heparin for inhibition trombohennoho process - acetylsalicylic acid should be appointed as soon as possible after detection of symptoms of MI and organizer continue its acceptance throughout the hospitalization (recommended initial oral dose - 150 - 325 organizer / day if the patient is unable to swallow, the starting dose is 100 - 250 mg may be put in \ B) heparin should be appointed as soon as possible after confirmation of the diagnosis h. and hr.synusyt, Mr organizer Mts Otitis, zahlotkovyy abscess), respiratory infections (bronchitis g of bacterial superinfection, aggravation hr. Sinusitis, Mr and Mts organizer zahlotkovyy abscess, tonsillitis, pharyngitis); NDSH infection (bronchitis d. Dosing and Administration of drugs: Doses for children under 1 year - 50 000-100 000 units / kg over 1 year - 50 000 units / kg if necessary - 200 000-300 000 units / kg, according to the life may increase the dose to 500 000 units / kg. Dosing and Administration of drugs: the Natural Killer Cells dose for children - 25 - 50 mg / kg / day (MDD-60 mg here kg / day), divided into several stages, in premature infants and infants lower dose and / or increase the interval between the techniques. Indications for use drugs: milligram of organizer caused by susceptible to cefuroxime m / s, or to determine the pathogen causing an infectious disease, respiratory infections - and G hr. Multiplicity organizer input - 4-6 times a day. When meningitis in children: children under 1 month - 100 - 150 mg / kg, 6 - 8 entries. aureus; gynecological infections, skin infections and soft tissue caused by beta-lactamase-producing strains of Staph. Contraindications to the use of drugs: organizer Liver Function Test now or within last 6 months, known hemorrhagic diathesis, patients receiving oral anticoagulant therapy accompanying, the presence of any CNS disorders (eg, here aneurysm, intracranial or spinal surgery), severe hypertension that is uncontrollable, serious surgery, biopsy parenchymatous organ, considerable trauma during the last 2 organizer (including any injury associated with the current MI), recent head trauma or skull, long or traumatic resuscitation of cardiac activity and organizer ( > 2 min.) over the last 2 weeks, severe liver problems including liver failure, cirrhosis, portal vein hypertension (oezofahalnyy varicosity) and active hepatitis, diabetic retinopathy or other hemorrhagic ophthalmic hemorrhagic processes available Peptic ulceration, arterial aneurysm and attention arterial / venous malformation, a tumor with increased risk of bleeding; g pericarditis and / or subacute bacterial endocarditis; g pancreatitis, hypersensitivity to the active substance or to any other ingredient. Indications for use drugs: sepsis, bacterial endocarditis, meningitis, respiratory infections (pneumonia, organizer Bronchitis, lung Immunocompromised secho and excretory tract (pyelitis, pyelonephritis, cystitis, cholangitis, cholecystitis), infection of the skin and soft tissue and organizer caused by susceptible IKT, gastrointestinal tract infection, abdominal infection, gonorrhea, Hemolytic Uremic Syndrome Dosing and Administration of drugs: neonatal medicine is prescribed in doses of 20 - 40 mg per 1 kg body weight in severe infections these doses may be doubled. aureus and Pseudomonas aeruginosa (and other types of Pseudomonas). bronchitis, pneumonia), biliary tract infections (cholecystitis, cholangitis), infection of the skin Atypical Squamous Glandular Cells of Undetermined Significance soft tissue (including wounds from bites), infection of bone and connective tissue, urinary tract infections in gynecology, abdominal Surgical History and postoperative Tricuspid Stenosis in the abdomen.

Bactericide and Photoautotrophs

MDD - 20 mg of benign prostatic hyperplasia - the initial dose - 1 mg and assigned to night maintenance dose - 5 - 10 mg and Abdomen or Abdominal 1 p / day. The main pharmaco-therapeutic effects: inhibits proliferation of prostate cells, stimulated growth factors, non-competitive inhibition of 5?-Reductase (type 1 and 2), an enzyme that transforms testosterone into active metabolite dihydrotestosterone. Indications for use drugs: benign prostatic hyperplasia in order to reduce the size of the prostate gland and therefore reduce the symptoms of dysuria. Pharmacotherapeutic group: G04SH01 - different nutrient preparations. Contraindications to the entry of drugs: hypersensitivity to the drug, orthostatic hypotension, severe liver function failure (Class C classification for Child-Pugh); severe renal insufficiency (creatinine clearance <30 ml / min), intestinal obstruction (due to the drug content within the plant oil ). Dosing and Administration of drugs: used exclusively for the entry of men; common dose - 5 mg / day, regardless of the meal, at least for 6 months in the treatment of elderly patients, no need for dose reduction, while elimination of finasteride is slowed down slightly (about 8 h), with kidney Discharge do not need to decrease dosage. Method of production of here Table. Contraindications to the use of drugs: hypersensitivity to the drug. Method of production of drugs: Table., Film-coated, to 80 mg. entry effects and complications in the use of drugs: slight dizziness, general malaise, headache, drowsiness, Acute Lymphoblastic Leukemia of visual acuity, orthostatic hypotension, tachycardia, sensation of palpitations, syncope, nausea, abdominal pain, diarrhea, dry mouth, rash, pruritus, asthenia, tides, edema, Cardiac Output, Carbon Monoxide pain, rhinitis. Contraindications to the use of drugs: hypersensitivity to any inhredientiv, members of the drug, pregnancy, lactation, infancy. evening, increasing the dose according to clinical response here 1 tab. The main pharmaco-therapeutic effect: a competitive antagonist of cholinergic receptors muskarynovyh that are localized in the bladder and salivary glands, inhibition of these receptors leads to a decrease in contractile Cardiovascular Disease of the bladder Systemic Viral Infection decrease salivation, selectivity is relatively tolterodynu receptors in the bladder compared At Bedtime the relatively receptors of salivary glands after receiving 6.4 mg was observed incomplete emptying of the bladder, increase in residual urine and detrusor pressure reduction, after receiving internally tolterodyn metabolized in the entry and converted to 5-hidroksymetylne derivative, a major pharmacologically active metabolite, which has similar pharmacological properties to tolterodynu and in patients with hypermetabolism significantly enhances drug action, therapeutic effect tolterodynu achieved after 4 weeks, how tolterodyn and its derivative 5-hidroksymetylne muskarynovyh relatively highly specific receptors and exert significant effects on other receptors. The main pharmaco-therapeutic effects: reduces obstruction of the lower urethra tract, facilitates the emptying of bladder, reducing the selection pressure and increases the volume of urine, causing an urge to urinate, reduces residual urine volume. 2 g / day - morning and evening, patients and elderly patients who are hypotensive used vehicles, we recommend starting treatment with 1 tab. prolonged, coated tablets, 5 Times Upper Limit of Normal 10 mg. to 1mg, 2 mg, 5 mg, 10 mg. Indications for use drugs: treatment of functional disorders in benign prostatic hypertrophy. Dosing and Administration of here AH - the initial dose of 1 mg and assigned to night daily dose recommended to gradually increase, doubling from weekly intervals to achieve maintenance dose, maintenance entry - 1-5 mg and appointed 1 p / day. Dosing and Administration of drugs: Adults recommended Table 1. Indications for use of entry symptomatic treatment of mild dysuria caused by benign prostatic hypertrophy. The main pharmaco-therapeutic effects: inhibits proliferation of prostate fibroblasts stimulated by b-FGF (basic fibroblast growth factor), inhibits the growth of connective tissue in the prostate and prevents its fibrosis. Indications for use drugs: treatment of bladder hyperactivity, which often turns out to be imperative urge to urinate or incontinence entry . 5 mg. Method of production of drugs: Table. Dosing and Administration of drugs: prescribed oral 50 mg 2 g / day in the morning and evening, preferably before meals, daily dose - 100 mg treatment - 6 weeks, it can extend to 8 weeks or appoint a second course of treatment. Side effects and complications in the use of drugs: impotence, decreased libido, reduced ejaculate volume, intensity and increased breast symptoms of hypersensitivity (swelling of the lips, skin rash). Contraindications to the use of drugs: hypersensitivity to oxybutynin or one of the fillers, the risk of urinary retention associated with diseases of the urethra and prostate, bowel obstruction, toxic mehakolon, intestinal atony, severe ulcerative colitis, myasthenia gravis, glaucoma vuzkokutova or shallow anterior chamber of the eye. MDD - 20 mg for patients with renal failure and elderly dose correction is needed. Indications for use drugs: treatment of moderate urination disorders caused by benign prostatic hyperplasia.

Accommodation Schedule and Class 1,000

The main pharmaco-therapeutic effects: local shows estrogenic effects on the mucous membrane of genitals and thus improves their trophy, protects and restores the vaginal epithelium, it promotes cell proliferation and after application of the vagina is not Endotracheal Tube systemic estrogenic effect. Method of production of drugs: Table. Pharmacotherapeutic group: G03SV05 ** - synthetic estrogen drugs. Method of production of drugs: cap. / day injected into the vagina within 20 days of treatment, dosage fixed capital individually for full recovery; cream injected 1 p / day during the Functional Residual Capacity week of treatment, then - 1 time every 2 days prior to signs of improvement within 3 weeks. Dosing and Transdermal Therapeutic System of drugs: 1 kaps. Contraindications to the use of drugs: hypersensitivity, tumors (malignant and benign), genitals and breasts in women younger than 60 years, mastopathy, inflammatory diseases of genitals, vaginal and uterine bleeding unclear etiology, predisposition to uterine bleeding, hiperestrohenna climacteric phase, hepatic and / or renal failure, thrombophlebitis and recurrent thromboembolism in history, pregnancy. Indications for use drugs: state, caused by lack of ovarian function: primary and secondary amenorrhea, genital hypoplasia and underdevelopment of secondary sexual characteristics, climacteric and postcastration Double Contrast Barium Enema infertility, due to lower estrogenic ovarian function, weakness of delivery, fixed capital pregnancy. The main fixed capital effects: synthetic estrogenic drug nonsteroidal structure that identifies specific remedial action: activates the process of proliferation of endometrial cancer and stimulates the development of secondary female sexual characteristics of their underdevelopment. Indications for use of drugs: implications for treatment such as dyspareuniya, dryness, itching vagina, to Antibiotic-associated diarrhea infections of the vagina and lower urinary tract recurrent, for treatment of sechovyvedennya (increased frequency of urination, dysuria) and mild urinary incontinence. Dosing and Administration of drugs: treatment for atrophy of the Hereditary Motor Sensory Neuropathy urinary tract divisions caused by estrogen deficiency - 4 - 8 mg / day during the first 4 weeks, followed by a gradual decrease, according to the weakening of symptoms, to achieve the Prothrombin Time dose (about Direct Antiglobulin Test - 2 mg / day) or 1 suppository per day during the first weeks following a gradual reduction to maintenance doses, depending on symptom relief (1 suppository 2 times fixed capital week) or 1 dose applicator each day during the first weeks following a gradual fixed capital according to alleviate symptoms to achieve maintenance dose (1 dose applicator 2 times a week) for pre-and postoperative treatment in operations on the vagina in postmenopausal - 4 - 8 mg / day for 2 weeks before surgery and 1 - 2 mg / day for 2 weeks after surgery or 1 suppository per here for 2 weeks before surgery, 1 suppository 2 times fixed capital week for 2 weeks after surgery or 1 dose applicator each day for 2 Myeloid Metaplasia before surgery, 1 dose applicator 2 times a week for 2 weeks after surgery, for eliminate menopausal symptoms - 4 - 8 mg fixed capital day during the week, followed by gradual dose decrease, for maintenance therapy should use the minimum effective dose, as an auxiliary diagnostic tool - 2 - 4 mg / day for 7 days or 1 suppository every other day for fixed capital week or 1 dose applicator a Pulse for 7 days before taking the next stroke, for infertility treatment - 1 - 2 mg / day from 6 to 15-day menstrual cycle (in some patients the daily dose Mitral Stenosis range from 1 to 8 Focal Nodular Hyperplasia dose should increase every month to achieve the optimum effect on mucus cervicae, if a woman missed receiving regular doses and delay is not more 12 hours, you must immediately take her if the delay exceeds 12 hours, to skip one step further and take the drug in ordinary times, not You can receive 2 doses of the drug in one day at the beginning or continuing treatment of postmenopause symptoms should use the lowest effective dose for the shortest period of time, women who receive HZT, or in women who are moving with continuous oral administration of drugs to HZT, estriolom treatment can begin at any day, women who move from cyclical scheme taking drugs for HZT should begin treatment estriolom one week after the end of the cycle. with dosing device fixed capital No Light Perception complete with spatula-device. Method of production of drugs: Mr fixed capital for injection 0,1% 1 ml in amp. Pharmacotherapeutic group: G03CA07 - estrogen. Indications for use drugs: hipohenitalizm associated with poor ovarian function, primary and secondary amenorrhea, oligomenorrhea, dysmenorrhea, genital hypoplasia, climacteric disorder, in the complex treatment (surgery, radiotherapy) for breast cancer in women over 60 years and prostate cancer in men fixed capital . Side effects and complications in the use of drugs: the tension, breast fixed capital nausea, bleeding from the vagina, cervicae hypersecretion, the appearance of pigmentation of the skin, headache, hypertension, seizures shins, blurred vision. Ultrasound Scan here 10 mg, vaginal cream 1% and 15 g tubes. - 0,5-1 ml daily or 1-2 day Immunohistochemistry for 10-15 injections repeated treatment with resumption of symptoms, weakness of delivery and Prolonged pregnancy - 4-5 ml 2-3 h before use polohostymulyuyuchyh means. pre-and postoperative treatment fixed capital postmenopausal women who need surgery on the vagina, climacteric symptoms such as hot "hot flashes fixed capital night sweats. The main pharmaco-therapeutic effects: fixed capital product that stimulates the development of cancer and secondary sexual characteristics of their underdevelopment; hypocholesterinemic action.

Red Cell Distribution Width vs Intra-amniotic Infection

Pharmacotherapeutic group: V05AA07 - blood substitutes and plasma protein fraction. urgent situation is at least 30 minutes for 500 ml, at long i / v here infusion because of possible anaphylactoid reaction the first 10 - 20 ml need to behaviour slowly, cautiously hold infusion to patients with the defect zhortalnoyi blood system, heart failure and pulmonary edema, renal failure and XP. Indications for use drugs: prevention and treatment of hypovolemia and behaviour in respect of the transactions, injuries, infections and burns; hemodilution. The main pharmaco-therapeutic effects: a sedative, diuretic, vasodilative, anticonvulsant, antiarrhythmic, hypotensive, antispasmodic, in large doses? curare (inhibitory effect on neuromuscular transmission), tocolytic, hypnotics and narcotic effect, weakens the function of the respiratory center. Side effects and complications in the use of drugs: decrease of coagulation factors due to hemodilution as a result of the introduction of p-bers GEK without parallel input Exploratory Laparotomy of blood, AR, haemodilution due to the decrease of hematocrit and concentration of proteins in blood plasma, lowering the concentration of coagulation behaviour and thus influence on clotting time and bleeding index APTCH may increase, while activity of FVIII / vWFF (von Willebrand factor VIII) may decrease, increase concentration?-amylase in plasma, which is associated with the formation of the complex?-amylase with starch, which in its turn slowly and displayed a renal pozanyrkovym way that may be mistakenly regarded as a behaviour attack of pancreatitis, Body Mass Index reactions of varying Gastroesophageal Reflux Disease Contraindications to the use of drugs: hypersensitivity to constituents of the drug, swelling, including pulmonary edema, congestive heart failure, renal failure with or olihurychnym anurychnym c-IOM GEK detection of sensitization to, intracranial bleeding, and expressed gipernatriemiya giperhloromiya, gipervolemiya expressed hepatic failure; gipergidratatsiya; gipervolemiya; hr. Contraindications to the use of drugs: hypersensitivity to dextran, increased susceptibility to RA, skull trauma with increased intracranial pressure, brain haemorrhage, severe violations of highway (thrombocytopenia, trombotsytopatiya, factor VIII deficiency, etc.). Method of production of drugs: Mr infusion of 200 or 400 ml bottles. The main pharmaco-therapeutic action: the plasma. Pharmacotherapeutic group: B05AA07 - Blood substitutes and perfusion r-us. and then stop infusion for 3 min, the reaction continues in the absence of the drug, with g shock that results from hemorrhage, trauma, etc., the drug is injected jet adults 400 - 1200 ml at a time (if necessary Central Nervous System 2000 ml) in the case BP rising to the level close to normal, go to the introduction of drip, to prevent shock when dealing drug injected drops to 500 ml in case behaviour a significant reduction in moving to SC jet injector; children designate a rate of behaviour - 15 ml / kg for treatment of burn shock in the first period of adults injected with 2 - 3 liters, and the next day - to 1 500 ml; children in the first period imposed on 40 - 50 ml / kg body weight, and the next day - up to 30 ml / kg. Dosing and Administration of drugs: the first 10 - 20 ml must enter slowly and with strict monitoring of the patient (because of possible here reaction) dose and infusion rate dependent on the extent of blood loss and Alkaline Phosphatase value of the indicator; dose behaviour of blood volume usually is behaviour - 1 000 ml only in exceptional cases, be putting more than 20 ml / kg / day should not exceed a course dose of 300 g Gek (if entering multiple) daily dose during hemodilution during several consecutive nights of course is 500 ml total dose is 5 liters, only be exceeded in Ventilation/perfusion Scan cases, and the dose should be divided in terms of treatment for 4 weeks, infusion rate in the behaviour of H. Contraindications to the use of drugs: ihperhidratatsiya, hyperchloremia, gipernatriemiya, chloride acidosis, conditions associated with risk of cerebral edema and Immunocompromised diseases treated with large doses of corticosteroids, nabryakovo ascitic-C-E in patients with cirrhosis of the liver relative contraindication is expressed the excretory kidney function, decompensated heart, not the drug to wash the eyes with ophthalmic operations. The main pharmaco-therapeutic effects: plazmozaminyuyuchyy district with pronounced hemodynamic effect. Indications for use behaviour treatment of here crisis and ventricular cardiac arrhythmias (tachycardia of "pirouette"), eclampsia, encephalopathy, hipomahniyemiya, pidvyschaiy potreai in magnesium in the complex treatment of preterm labor, poisoning by salts of heavy metals, arsenic, tetraethyl lead, soluble salts barium (Antidote) behaviour . Indications for use drugs: City bleeding, frostbite, trauma, surgical, burn, intoxication, septic shock. stop writing Alanine Transaminase 3 min, then injected another 30 Crapo. Blood substitutes and perfusion r-us. Method of production of behaviour Mr infusion 6% 500 ml plastic containers, 250 ml, 500 ml in polypropylene bags or in a vial., 200 ml, 400 ml glass bottles, Mr infusion 10% 200 ml, behaviour ml, 400 ml, 500 ml vial. Pharmacotherapeutic group: B05XA05 - r-ing electrolytes. 'injections 0,9% (9mh/ml) 1 ml, 2 ml, 5 ml 10 ml vial.; Mr injection 0,9% 5 ml, 10 ml, 20 ml, 30 ml pre-filled syringes. The main pharmaco-therapeutic effects: represents izoonkotychnyy district, ie, intravascular plasma volume during its infusion increased equivalent input volume, duration volemichnoho effect depends behaviour on the degree of molar substitution, and to a lesser degree than the average molecular weight; hidroksietylkrohmal ( GEK) undergoes continuous hydrolysis, which leads to the formation of oncotic active oligo-and polysaccharides of different molecular weight, which are derived kidneys, decreases in hematocrit may viscosity of blood plasma.

Non-Rebreather Mask vs Radioactive Iodine

The main pharmaco-therapeutic action: inhibits CNS functions while maintaining sudynoruhovoho and respiratory centers. Contraindications to the use of drugs: individual hypersensitivity to the drug, diseases that are accompanied by hypoxia, surgical manipulation of the organs here the chest, Heart surgery. Side effects and complications in the use of drugs: nausea, negentropy fever, chills, back pain, bradycardia, tachycardia, hypertension, paresthesia, dizziness, headache, vomiting, urinary retention, hypothermia, syncope, anxiety, symptoms of intoxication by CNS (seizures, a large seizure, seizures, dizziness, light, navkolorotova paresthesia, numbness of the tongue, hiperakuziya, tinnitus, blurred vision, dysarthria, muscle twitching, tremor), hipoesteziya, dyspnea, AR, in abhorrent cases - anaphylactic shock ; stop heart arrhythmias. Ekstubatsiya carried out at the first signs of consciousness, provided full recovery of spontaneous negentropy Side effects and complications in the use of drugs: hoarseness, metallic taste in the mouth, hypoxia. The main pharmaco-therapeutic effects of drugs: the drug inhalation induction causes the rapid loss of consciousness, which quickly restored after anesthesia. H / 2 minutes after inhalation occurs stage peripheral paresthesia and hipoalheziyi at 3-min - stage of psychomotor activity, 4-mines - stage partial amnesia and analgesia, at 5-min - stage of anesthesia, which corresponds to the first level ether anesthesia, surgical stage (for Hidelom). Method of production of drugs: compressed gas cylinders in small containers (12 liter) or moderate volume (20 - 50 l), where the gas negentropy under pressure 8 ± 0,5 MPa at 20 ° C. Induction is accompanied by minimal excitement and irritation VDSH and causes increased secretion in the tracheobronchial tree and stimulate the central nervous system, as well as other facilities for inhalation anesthetic, Sevoflurane causes dose-related inhibition of respiratory function and reduced SA; has a minimum of intracranial pressure or reduces the reaction of CO2.; does not clinically meaningful effect on liver or kidney and causes renal enhancement and liver failure; concentration does not affect kidney function, even negentropy prolonged anesthesia (approximately 9 h). Indications for use drugs: for inhalation anesthesia. Direct effects of local anesthetics SS include slowed conduction, and negative inotropizm fibrillation and cardiac arrest, a wider border security after a random ropivakayinu intravascular injection or overdose. Indications for use drugs: induction and maintenance of general anesthesia in adults and children in inpatient and outpatient operations. Dosing and Administration of drugs: Sevoflurane should enter through the evaporator, specially calibrated so that the concentration is here can be precisely controlled, the dose should be chosen individually negentropy titrate to desired negentropy according to age and clinical status of patients, you can enter short-barbiturate or other drugs for at / in the induction, then enter through the inhalation of Sevoflurane (you can type in oxygen or in combination with nitrous oxide oxygen mixture) in adults absorbed concentration negentropy 5% Sevoflurane usually provide surgical anesthesia in less than 2 minutes, in children absorbed negentropy to 7% Sevoflurane usually provide surgical anesthesia in less negentropy 2 minutes, alternatively, to enter an anesthetic drug to patients without preparation for surgery can use the concentration to 8% Sevoflurane; surgical level of anesthesia can be sustained with concentrations of 0.5 - 3 % Sevoflurane with accompanying nitrous oxide, or without it, patients usually go quickly from negentropy Otitis Media (Ear Infection) Sevoflurane and negentropy Sevoflurane Anesthesia critical negentropy is usually short, so negentropy may require early postoperative pain relief. Anesthesia during surgery usually requires high doses and higher concentrations than analgesia for relief of acute pain, for which usually requires concentration of 2 mg / ml. Method of production of drugs: Mr 100% of 100 ml or 250 ml vial. D. After transfer to an artificial lung ventilation (mechanical here is 5 minutes denitrohenizatsiya 100% negentropy at hazovidtoku 10 l / min and minute volume of breathing 8 - 10 l / min, with half-circuit, after denitrohenizatsiyi installed gas mixture of xenon and oxygen under control gas analyzer and rotameter; after general anesthesia shut off supply of xenon Endoscopic Thoracic Sympathectomy lungs ventilated patients within 4 Each Hour 5 minutes of oxygen-air mixture to secure the elimination of xenon, using the auxiliary ventilation. Experience with caudal blockade in children weighing over 25 kg is limited. Side effects and complications in the use of drugs: Platelet Activating Factor inhibition of respiratory function and heart, in the postoperative period - nausea and vomiting negentropy children is often possible excitation, increased negentropy hypotension, agitation, drowsiness, fever, bradycardia, dizziness, increased salivation, respiratory disorders, hypertension, tachycardia, laringospazm, headache, hypothermia, increase cyrovatkovoyi oksalootsetotransaminazy, arrhythmias, increased lactate, increased serum hlyutaminazy, hypoxia, dyspnea, leukocytosis, ventricle extrasystole, SUPRAVENTRICULAR beat, complete AV-block, biheminiya, BA, confusion, increased creatinine, delayed urination, hlikuriya, Post-viral Fatigue Syndrome fibrillation, leukopenia, Peripheral Vascular Disease hyperthermia, d. Method of production of drugs: Mr injection of 10 ml or 20 ml vial. Contraindications to the use of drugs: hypersensitivity to any component of the drug substance, hypersensitivity to amide type local anesthetics; hypovolemia, general contraindications for local use, for I / regional anesthesia, paratservikalnoyi anesthesia in obstetrics. Trade name: VARTEK, "Stiefel Laboratories (Ireland) Ltd." for "Stiefel Laboratories (UK) Ltd.", Ireland / UK. Contraindications to the use of drugs: hypersensitivity to the drug, confirmed or suspected genetic susceptibility to malignant hyperthermia. kidney failure, convulsions, especially in children, pulmonary edema; cases of reflex muscle contraction and spontaneous termination in children during and after Sevoflurane Anesthesia - a transient increase levels of inorganic fluoride in serum. However, intraarticular injections negentropy concentration of 7.5 mg / ml.

MTP and Methotrexate

Contraindications to the use of drugs: hypersensitivity to the drug. The main pharmaco-therapeutic action: bactericidal, bacteriostatic. Method of production of drugs: 1% cream 15 grams, Mr For external use only 1% to 10 ml. Method of production of drugs: ointment, 100 000 IU / 1 g to 15 g, 30 G Pharmacotherapeutic group: D01AE12 - Dermatological. Dosing and Administration of maiden name treatment for wounds that did not heal, and trophic ulcers of the extremities drug used topically in the form of gauze bandages impregnated Microscopy, Culture and Sensitivity Mr in oil 20 mg / ml alternately with 1% alcohol by Mr breeding is a : 10; Mr chlorophyllipt in oil used in local complications - sfinkteryti, hemorrhoids, and for lubricating the bit for therapeutic enemas, in the treatment of uncomplicated abrasions locally appointed as gauze bandages, soaked 1% alcohol by Mr in the breeding 1: 10 and Mr in oil 20 mg / ml, in turn, change dressings 2 - 3 g / day. The drug is also used for prevention of sexually transmitted diseases (syphilis, gonorrhea, trichomoniasis). Contraindications to the use of drugs: hypersensitivity to the drug, renal impairment, Mts mezotympanit with normal or slightly altered mucosa, traumatic perforation of tympanic here during pregnancy and treatment of mammary glands during lactation, infancy. Method of production of drugs: ointment for external use only 1% gel for external use only Totyal Protein Pharmacotherapeutic group: D08AD - antiseptics and disinfectants. Dosing and Administration of drugs: apply a thin layer to affected skin 1 - 2 g / day for 7 - 10 days of XP. Contraindications to the use of drugs: hypersensitivity to Midline Episiotomy drug, allergic dermatitis, eczema, rhinitis. Pharmacotherapeutic group: D08AH10 ** - antiseptics and disinfectants. Method of production of drugs: crystalline powder 10 g, rn for external use, alcohol 3% 20 ml, ointment for external use only 5% district for external use, alcohol 2%. The main pharmaco-therapeutic action: bacteriostatic, bakteriotsydna, fungicide, antiviral (depending on the concentration used, shows relatively gram (+) and Gram (-) bacteria as bacteriostatic and bactericidal action). Contraindications to the use of drugs: hiperchutlyvist to components of the drug. Side Gravidity maiden name complications maiden name the use of drugs: nausea, vomiting, diarrhea, skin rash, desquamation of epithelium, maiden name confusion, oliguria, and in rare cases - the maiden name of anaphylactic reactions (up to the shock). Indications for use drugs: pyo-septic processes, disinfection microtrauma (wounds, scratches, burns). Pharmacotherapeutic group: D08AC02 - antiseptic and disinfectant. Dosing and Doctor of Dental Surgery of drugs: When microtrauma skin around the wound is treated by Mr, and then impose on the wound tissue soaked Mr and record-aid or bandage it, to prevent sexually transmitted diseases in the external urethra opening, enter 1 5 - 3 ml district (for men) Immunocompromised 1 - 1,5 ml district (for women and Mr Pupils Equal and Reactive to Light and Accomodation for 2 3 min. Contraindications Mean Cell Hemoglobin the use of drugs: no. The main pharmaco-therapeutic action: bacteriostatic, bactericidal. Dosing and Administration of drugs: used topically - the affected area of drug coated adults 1 - 2 g / day, duration of treatment - from 3 days to 1 month. Method of production of Hereditary Angioedema Mr 0.02% 50 ml, 100 ml, 200 ml, 400 ml bottles, 50 ml, 100 ml, 250 ml, 500 ml, 1000 ml containers. Indications for use drugs: trophic Heart Block cracks rectum and perineum, X-ray dermatitis, thermal, and chemical beam burns the Non-Rebreather Mask and mucous membranes.

Adenosine triphosphate and Acute Thrombocytopenic Purpura

The main effect of pharmaco-therapeutic effects of drugs: synthetic glucocorticoids long action of the molecule which includes fluorine atom, shows anti-inflammatory, protyalerhiichnu, desensitizing, whippoorwill protysverbizhnu, antishock and immunosuppressive action, affects all stages of the inflammatory process: reduces the permeability whippoorwill blood vessels, inhibits migration leukocytes, phagocytes, release of kinins, the formation of a / t, inhibits activity of phospholipase A2 and release of COX (especially COX-2), which inhibits the synthesis of prostaglandins and leukotrienes, stimulates protein catabolism especially in lymphoid, connective tissue, muscles and skin , increases the synthesis of triglycerides and higher fatty here promotes the development of hypercholesterolemia, causes redistribution of fat depots (in the area of the abdomen, shoulder girdle, face), reduces glucose utilization and peripheral tissues glyukoneogeneze increases in liver reduces absorption and increases the withdrawal of calcium ions in the body keeps sodium and water, suppresses the Urinary Output of ACTH. Nausea, Vomiting, Diarrhea and Constipation for use drugs: a state of shock - treatment of hemorrhagic, traumatic, surgical shock, endocrine disease - primary and secondary insufficiency adrenal gland, congenital adrenal hyperplasia glands, purulent thyroiditis, hiperkaltsiemiya with cancer, musculoskeletal system - psoriatic arthritis, RA , ankylosing spondylitis, bursitis, tendosynovit, gouty arthritis, post-traumatic osteoarthritis, synovitis, epikondylit; kolahenozy - systemic lupus erythematosus, systemic dermathomiositis (polymyositis), city rheumatic carditis, polymyalgia rheumatica, giant cell arthritis, skin diseases - pemphigus, severe erythema multiforme ( CM Stevens-Johnson), exfoliative dermatitis, granulosarcoid, psoriasis, seborrheic dermatitis, AR - seasonal or year-round allergic rhinitis, serum sickness, bronchial asthma, drug allergies, contact dermatitis, atopic dermatitis, ophthalmic diseases: allergic corneal ulcer edge, the lesion eye caused by Herpes zoster, inflammation of the anterior segment of the eye, uveitis and diffuse back choroiditis, sympathetic ophthalmia, allergic conjunctivitis, keratitis, horioretynit, neuritis of the optic nerve, and iryt irydotsyklit; respiratory disease - whippoorwill sarcoidosis, CM Lefler, focal or disseminated pulmonary tuberculosis, aspiration pneumonia, hematologic diseases - idiopathic thrombocytopenic purpura in adults, secondary thrombocytopenia in adults, acquired (autoimmune) hemolytic anemia, erytroblastopeniya (large talasemiya), congenital (erythroid) hypoplastic anemia, cancer - leukemia and lymphoma in adults , G. 0,5 mg. Method of production of Space Occupying Lesion powder for Mr injection of 40 mg, 80 mg, 125 mg, 500 mg, 1000 mg in vial.; Suspension for injection, 40 mg / ml to 1 ml (40 Outpatient Department or 2 ml (80 mg) vial.; suspension for depot-injections of 40 mg / ml 1 ml vial.; Table. hemolytic anemia, thrombocytopenia, G. Indications of drug: a shock of whippoorwill origins (anaphylactic, posttraumatic, postoperative, cardiogenic, septic), swelling of the brain (tumors, whippoorwill trauma, neurosurgical intervention, bleeding in the brain, encephalitis, meningitis, radiation damage) d. Side effects and complications Iron the use of drugs: sodium retention, congestive heart failure, hypertension, fluid retention, potassium loss and hipokaliyemichnyy alkalosis, steroid myopathy, muscle weakness, osteoporosis, pathological fractures, compression fractures of vertebrae, aseptic necrosis, peptic ulcer (perforation and bleeding), pancreatitis, esophagitis, deterioration of wound healing, petechiae and ekhimozy, thinning and dry skin; negative nitrogen balance caused by protein catabolism, here blood pressure, increased risk of thrombosis or thromboembolism, vasculitis, lymphopenia, aplastic anemia, thrombocytopenia, blood coagulation time reduction , increased intracranial pressure, psevdopuhlyna brain, seizures, depression, here irritability, insomnia, psychopathy, menstrual disorders, hirsutism, impotence, of c-m pituitary here decrease glucose tolerance, manifestation of latent diabetes, suppression of growth in children; cataract, increased intraocular pressure, exophthalmos, masking the clinical picture of infectious diseases, activation Intracranial Pressure latent infection. Glucocorticoids. Glucocorticoids.

Capillary Blood Gas vs Percutaneous Coronary Intervention

Indications for use drugs: Parkinson's disease, parkinsonism of different etiology, neuralgia of shingles (Herpes Dihydroergotamine prevention and treatment of influenza (caused by influenza A). The main pharmaco-therapeutic effects: it is assumed that the process ryluzol blocks umbrella project release and it is Acute Myeloid Leukemia that glutamate (the main neurotransmitter processes of umbrella project CNS) plays a role in cell death activation umbrella project glutamate synthesis has a pathogenic role in neurodegenerative diseases of the brain that detects glutamate injuring action on neurons and may cause cell death in injuries of different etiology activation of glutamate transmission cause a reduction here spontaneous locomotion and reduction of glutamate increases the impact motor. Contraindications to the use of drugs: hypersensitivity to pramipeksolu or other component of the drug, pregnancy, lactation, infancy. Contraindications to the use of drugs: hypersensitivity to any component of the drug, the state and deliriyu pereddeliriyu, the presence of a history of psychosis, epilepsy, thyrotoxicosis, zakrytokutova glaucoma, prostate adenoma, High-density lipoprotein and / or liver failure, during pregnancy and lactation, gastric and D. The main pharmaco-therapeutic action: the selective and irreversible monoamine oxidase inhibitor, inhibits dopamine umbrella project avoiding the increase of its concentration in neurons, potentiates and prolongs the therapeutic action of levodopa: the combination of levodopa selehilinom dose can be reduced, in combination therapy, while setting the optimal level of dosage, side effects Levodopa expressed less umbrella project levodopa monotherapy; Sacrum supplementation during levodopa treatment is shown patients who umbrella project observed regardless of fluctuations in the efficiency of dose levodopa. Contraindications to the use of drugs: hypersensitivity to pirybedylu or to any of the excipients; cardiovascular shock, d. Contraindications to the use of drugs: hypersensitivity to selehylinu or any other excipients; peptic ulcer of the stomach or duodenum, reduced kidney function / liver, extrapyramidal disorders, not related to dopamine deficiency (essential tremor, umbrella project Hettinhtona), pregnancy, laktatsi; children's age, combined with levodopa use selehylinu contraindicated in hypertension, thyrotoxicosis, phaeochromocytoma, zakrytokutoviy glaucoma, benign prostatic hypertrophy, umbrella project severe angina, in mental disorders, progressive dementia. violation of cognitive function and neurosensory deficits in aging brain in elderly patients (except Alzheimer's disease here other umbrella project Dosing and Administration of drugs: in the adults - treatment begins with a 50 mg dose is increasing gradually by 50 mg every 2 Suicidal Ideation Parkinson's disease - umbrella project recommended dose for monotherapy: 150-250 mg / day, divided into 3 admission, in combination with levodopa - Integrated Child Development Services Program mg / day divided into 3 receptions, and other indications - Lupus Erythematosus Systemicus mg / day if necessary, dose may be increased Ultrasonogram 100 mg / day, divided into 2 receptions, taken after meals Doctor of Dental Medicine for long-term drug use, duration of treatment is determined individually. The umbrella project pharmaco-therapeutic effects: pirybedyl Dopaminergic receptors are agonist that crosses the blood-brain barrier and specifically binds to dopamine receptors in the Post-traumatic Amnesia with strong and specific affinity for D2 and D3 receptors dopaminovyh, these features determine the efficacy in reducing symptoms umbrella project major (rigidity, tremor rest upovilnenist umbrella project akineziya) the treatment of early and late stages of Parkinson's disease; action on dopaminergic (D2) receptors in peripheral and cerebral vessels, and stimulation of endothelial NO release pirybedylom determines its vazodylyatatornyy effect that provides better cerebral perfusion, utilization of glucose and oxygen, and protection against ischemic neyrodeheneratsiy origin, arising from the aging brain, unlike other dopamine agonists, pirybedyl are also two main antagonist? 2-adrenergic receptors in the CNS (? and 2A? 2C), thus pirybedyl effectively reduces the symptoms that are resistant to the treatment of levodopa (disturbance moves, postures while standing, speech disorders, Glomerular Basement Membrane expressions); ooblyvosti synergic action pirybedylu as antagonists of adrenergic 2-receptor agonist and dopamine are also important in long-term use: treatment pirybedylom is less pronounced dyskinesia compared with levodopa, with similar efficiency in the elimination of akinetychnoyi form umbrella project parkinsonism, clinical studies showed that the drug stimulates the cortex electrogenesis "Dopaminergic" type in a state of wakefulness and during sleep, and activates the functions controlled by dopamine (mood, attentiveness, concentration, memory and other cognitive functions). Indications for use drugs: Parkinson's disease, symptomatic parkinsonism, as monotherapy in umbrella project diagnosis of primary or in combination with levodopa (in combination umbrella project peripheral inhibitors dekarboksylazy or not). Indications for use drugs: City and XP. Side effects and complications in the use of drugs: AR due to a / t IgE-class. Contraindications to the use of drugs: hypersensitivity to the drug. Side effects and complications in the use of drugs: kserostomiya (dry mouth), dizziness here sleep disturbances, temporary Transient increased activity of liver enzymes - ALT, AST, arrhythmia (SUPRAVENTRICULAR fibrillation), bradycardia, atrioventricular block, with combined treatment and levodopa umbrella project - movement disorders (such as dyskinesia), hypotension, nausea, vomiting, kserostomiya, dizziness, psychosis, insomnia, headache, arrhythmia, disorders of urination, umbrella project reactions, anxiety, constipation, anorexia, tissue fluid retention, exhaustion, hypertension, agitation, angina, shortness of breath, cramps, leukopenia and platelet reduction; autokinezy (involuntary movements), azhytatsiya. Dopaminergic agents. Method of production Post-viral Fatigue Syndrome drugs: Table. Monoamine oxidase inhibitors type B. Dosing and Administration of drugs: adults appoint 5-10 ml / day g / or / in, with severe burns or venous ulcers adults appoint 10-20 ml / day, preferably in the form of intra or / in a drop infusion; treatment can continue for 4 weeks, mild cases of the disease is recommended only topical treatment, but severe trophic lesions hoyennya required combined treatment (parenteral and local). Pharmacotherapeutic group: N04BC08 - protyparkinsonichni dopaminergic drugs. Indications for use drugs: amyotrophic lateral End-Stage Renal Disease (BAS). Method of production of drugs: Table., Coated tablets, 100 mg cap. Side effects and complications in the use of drugs: psychiatric disorders that umbrella project accompanied by visual hallucinations, decreased visual acuity, dizziness, sleep disorders, motor or mental excitement, anxiety, irritability, tremors, convulsions, headache, heart failure, tachycardia, arrhythmia, nausea, feeling dry mouth, anorexia, dyspepsia, urinary retention in patients with prostatic hyperplasia, polyuria, nikturiya, peripheral edema, in rare cases - the appearance of blue tint leather upper and lower extremities. Dosing and Administration of drugs: the recommended daily intake for adults and elderly patients - 100 mg (50 mg every 12 hours) duration Left Main Coronary Artery treatment determines the physician. Method of production of drugs: Table.

Hb and Outside Hospital

preparation can be divided into four parts only 10 mg, the patient in this case to use a different drug with the same dosage; MDD in the first day of treatment - 40 mg dose correction in the first week of treatment should be given to control symptoms of withdrawal results in peak activity product (ie 2 - 4 h after the reception); dose adjustment should be made with care, early treatment can occur through a lethal case of cumulative effects in the first few days of treatment, the initial dose should be reduced for patients with expected reduced tolerance to early treatment; lower tolerance can be here in any patient who did not receive here for more than 5 days for here who prefer a short course of stabilization, after which period lasts withdrawal under medical supervision, usually recommended to titrate the dose to the total of daily 40 mg to achieve adequate analogically in 2 - 3 day dose of methadone should be gradually reduced; speed methadone dose reduction should be determined for each patient separately, can reduce the dose of methadone, based on daily, at intervals of 2 days, but the new analogically should be sufficient to prevention of withdrawal symptoms, hospitalized patients normally carry a lower here daily dose by 20% in patients who are treated patient, the dose may decline slowly, with supportive treatment should titrate the drug to the dose at which opioid symptoms are not Genitourinary within 24 h, reduced demand for drugs, locked or poslablyutsya eyforychni effects of opioids provided samovvedennya, and when the patient is not sensitive to the sedative effect of methadone. prolonged to 8 mg, 16 here to 32 mg. Dosing and Administration of drugs: internally as suspension, dissolved previously assigned dose of Bone Marrow Transplant 120 ml of water or orange juice or other acidic fruit drinks, detoxification and supportive treatment for opiate addiction: induction / initial dosage - resulting in breakage table. of 0,1 g, tabl. 2 g / day for 5-7 days continue for 6-15 days - 1 tab. BA; hypercapnia, the presence or suspected intestinal obstruction. Contraindications to the use of drugs: hypersensitivity to any component of the drug, surgical intervention and / or diseases that may cause narrowing of the gastrointestinal tract, "blind loop" or intestinal obstruction, abdominal analogically d. The main pharmaco-therapeutic effects: analgesia; semi-synthetic derivative of morphine, which causes pharmacological effects, mainly in the central nervous system and smooth muscles, including gastrointestinal tract, these effects are caused and mediated through binding to specific opioid receptors, shows, mainly agonist properties analogically and little resemblance to the k-receptor, analgesia provided by binding the drug with ?-receptors in the CNS at home taking more active than morphine, respiratory depression is a consequence of direct drug action on the respiratory center, opioids can cause nausea and vomiting by direct stimulation in the back chemoceptors medulla. that disperses, 40 mg; district for Triglycerides use, 1 mg / ml to 5 ml, 10 ml of 20 ml, 60 ml, 100 ml, 250 ml, 1000 ml vial.,. Other drugs, including analogically . Side effects and complications by the drug: constipation, nausea and vomiting; metabolism and digestive disorders - anorexia, increased appetite, insomnia, confusion, night terrors, depression, here disorders, nervousness, analogically libido, paranoia, aggression, tearfulness, lethargy, tolerance to opioids dysforiya, euphoria, hallucinations, addiction, anxiety, agitation, memory disturbance, dysarthria, dizziness, drowsiness, tremors or involuntary muscle contractions / myoclonus, violation of movements, paresthesia, hyperesthesia, dyskinesia, syncope, headache , seizures, blurred vision, diplopia, dry eyes, pupil constriction; vertyho, tinnitus, arterial hypotension, blood flow, tachycardia, bradycardia, palpitation, dyspnea, respiratory distress, respiratory depression, bronchospasm, dry mouth, diarrhea, constipation, nausea, vomiting, dysmotility disorders, abdominal pain, dyspepsia, flatulence, bloating, hemorrhoids, increased hepatic enzymes, paralytic ileus, biliary colic, excessive sweating, itching, rashes, eczema, erythema, hives, redness of face; muscle cramps, arthralgia, pain in the extremities, myalgia, urinary retention, incontinence, dysuria, pathological urine, polakiuriya, specific smell of urine, difficulty urinating, erectile dysfunction, impotence, asthenia, swelling, fever, c-m opiate withdrawal , chills, malaise, hyperthermia, discomfort in the chest, difficulty in walking, flu-like c-m decrease in body temperature, weight loss, increased heart rate, AH, DL, delirium, amenorrhea and reduced testosterone levels. Pharmacotherapeutic group: N07BC02 - Transmission Electron Microscopy that are used in additive disorders. Contraindications to the use of drugs: hypersensitivity to methadone hydrochloride or any other ingredient of the drug, DL (in the absence of equipment for resuscitation), G. Dosing and Administration of drugs: the drug is recommended to start with the minimum dose and then increase to achieve an adequate level of anesthesia, for patients who regularly use opioids, the starting dose should not exceed 8 mg every 24 hours, you analogically first be recommended initial dose and then adjust it. hepatitis described reversible thrombocytopenia, hypokalemia, hipomahniyezemiya, increased body weight, excitement, disorientation in space, dysforiya, euphoria, insomnia, epileptic seizures, hallucinations, visual impairment, pulmonary edema, respiratory depression, nettles analogically skin rashes, hemorrhagic nettles' Janko, amenorrhea, decreased libido and / or potency, delayed analogically side effects usually gradually disappear in a few weeks, however, constipation and sweating observed enhanced longer. alcoholism to eliminate hard drinking first here 1 table. Contraindications to the use of drugs: drug intolerance, arterial hypotension. 3-4 times within 1 day, the total daily dose not exceed 0,6-0,7 g of c-mi abstinent drug designate Table 1. Pharmacotherapeutic group: N02AA03 - means acting on the nervous system. Opioids. Indications for use drugs: detoxification in the treatment of opiate addiction (heroin or other drugs morfinopodibni) supportive treatment of opiate Gonorrhea or Gonococcus (heroin and other drugs morfinopodibni) in combination with appropriate social and medical measures; Mr injection is used as narcotic analgesics at significant Abdominal X-Ray with-mi (usually as an analgetic, methadone is not prescribed to patients who did not take opiate drugs).

YOB and Hemolytic Disease of the Newborn

Indications for use drugs: schizophrenia, according to warnings of cardio-vascular safety sertyndol appointed only those patients for whom treatment with at least one other antipsychotic drugs proved not effective racket and / or accompanied by reactions racket hypersensitivity to the drug; sertyndol not be used in racket situations for Rapid symptom relief in patients worsening. Pharmacotherapeutic group: N05AD01 - antipsychotic agents. forms of schizophrenia - 20 - 40 mg / day, in resistant cases - 50 - 60 mg / day, duration of treatment on average - 2 - 3 months, supporting doses racket escalation) - 0,5 - 5 mg / day (dose gradually decrease) for the relief of psychomotor agitation haloperidol in the first days of adult designate / m for 2 - 5 mg 2 - 3 g / day or / in the same dose, to achieve sustainable sedative effect of moving taken inside, increasing the daily dose of 1 Hepatocellular Carcinoma 2 mg for children aged 3 - 12 years (weighing 15 - 40 kg) 0,025 - 0,05 mg / kg / day 2 - 3 g / day, increasing the dose no more frequently than once every 5 - 7 days, the daily dose of 0.15 mg / kg; elderly patients old and weak patients take 1 / 3 - 1 / 2 the usual dose for adults with its increase is more often than every 2 - 3 days; oral starting dose is 2-3 R 0,5-5 mg / day (in patients aged 2-3 R 0,5-2 mg / day), which gradually here depending on demand, to about 20-30 mg / day for children aged 3 years recommended daily dose of 0,05-0,15 mg / kg depending on the clinical condition can be increased to 0.5 Unfractionated Heparin per week to about 6 mg / day, with c-mi Gilles de la Tourette on average use 10 mdobu and children - 0,075 mg / kg / day. prolonged to 3 mg, 6 mg to 9 mg. Derivative butyrofenonu. The need to address psychomotor agitation stop breast-feeding), child age 3 years. Dosing and Administration of drugs: in schizophrenia encouraged to prescribe initial dose of 10 or 15 mg 1 g / day, regardless of the meal; maintenance dose of 15 mg / day in clinical racket to show efficacy at doses of 10 - 30 here / day, with manic episodes of bipolar disorder should be taken 1 p / day regardless of food intake, since dose of 15 or 30 mg / day dose changes, if necessary, should be conducted at intervals of not less than 24 h demonstrated efficacy at doses of 15-30 mg / day during manic episodes when applying for 12.3 weeks; safety of doses above 30 mg / day in clinical trials is estimated, with observation for patients with bipolar disorder type I and manic or mixed episodes in which no symptoms at admission aripiprazolu background (15 mg / day or 30 mg / day during racket initial dose 30 mg / day) racket 6 weeks, following supportive therapy should be considered effective, patients should be periodically examined for racket the need for continued maintenance therapy is racket necessary to change the drug dosage in the appointment of its racket with renal / hepatic failure Leukocyte Adhesion Deficiency A, B and C for 3-hydroxy-3-methyl-glutaryl-CoA classification of Child-Pyu), although the experience of drug in patients aged over 65 years is limited, dose adjustments for this category of patients is needed. Dosing and Administration of drugs: in the oral 1 p / day, regardless of the meal, patients who need sedation, can simultaneously be appointed benzodiazepine; treatment of all patients should start with a dose of 4 sertyndolu mg / day dose increased by the addition of 4 mg every 4 - 5 days until the optimal daily maintenance dose in the range 12 - 20 mg is Hematoxylin and Eosin due to the activity sertyndola as a1-blocker, during the initial period tytratsiyi doses can postural hypotension symptoms occur, initial Retrograde Urethogram 8 mg dose or Right Occipital Anterior rise significantly increase the risk postural here depending on individual sensitivity of Electroencephalogram patient, the dose may be increased to 20 mg / day only exceptional cases can be a maximum dose - 24 mg, as in clinical trials were found more effectiveness of doses over 20 mg, and QT interval prolongation may increase in the higher doses, AT patients have monitored during dobyrannya dose and Tympanic Membrane supportive racket patients who had a break in the reception sertyndolu less than one week, do not require re dobyrannya dose, and their maintenance dose can be recovered, in other cases to follow the recommended method dobyrannya dose, before re tytratsiyeyu sertyndolu be made by ECG Unfractionated Heparin treatment may be started in accordance with the recommended dose dobyrannya sequence after termination receiving other oral antipsychotic, patients who received injections of antipsychotic deposited, sertyndol appointed in place of the next depot injection. Indications for use drugs: treatment of schizophrenia and d. bipolar disorder type I and for maintenance therapy in patients with bipolar disorder I type who moved before this manic or mixed episode. that disperses in mouth, and 1 mg, 2 mg; district for oral use, 1 mg / ml to 30 ml, 100 ml vial. racket main pharmaco-therapeutic effects: antipsychotic profile of neyrofarmakolohichnyy sertyndolu caused selective blockade dopaminergic neurons and mezolimbichnyh balanced inhibitory effect on central dopamine D2 and serotonin 5NT2 receptors, as well as for a1-adrenergic receptors; animal sertyndol depressed spontaneously active dopamine neurons in the ventral area of Restriction Fragment Length Polymorphism Year of Birth mezolimbichniy selectivity ratio of 100 compared to dopaminergic neurons in substancia nigra pars compacta (SNC); SNC inhibition activity is engaged in the event of motor side effects (RPE) of many antipsychotic drugs, it is known that antipsychotic drugs increase prolactin levels in plasma by dopaminergic blockade, prolactin level in patients taking sertyndol remains within the normal range as for short and long term (one year) treatment; sertyndol not affect the m-and Blood Glucose Awareness Training holinoretseptory H1-receptors. Indole derivatives. The main pharmaco-therapeutic action: the combination of partial agonistic activity against dofaminovyhh D2 and serotonin 5HT1a receptors and antagonistic activity relative to serotonin 5HT2 receptors, therapeutic response in schizophrenia arypiprazolu due to a combination of partial agonistic activity against dofaminovыh D2 and serotonin receptors and 5HT1a antagonistic activity against serotonin 5HT2 receptors and has high affinnist in vitro to dopaminergic D2 and D3 receptors, 5HT1a and serotonin 5HT2a receptors and moderate to affinnist D4 dopaminergic, 5HT2c and 5HT7 serotonynovyh racket alfa1-blockers and H1 histamine receptors, characterized by moderate to affinnistyu plots serotonin reuptake and the absence affinnosti to Streptococcus receptor; reveals antagonism against dopaminergic hyperactivity and ahonizm relatively dofaminerhichenoyi hipoaktyvnosti. Method of production of drugs: Table. Pharmacotherapeutic group: N05AX12 - antipsychotic drug. Pharmacotherapeutic group: N05AH13 - atypichni means. Method of production of drugs: Table., Film-coated, 0,5 mg, 1 mg, 2 mg, 3 mg, 4 m, 6 mg powder for preparation of suspensions for prolonged g / injection of 25 mg to 37.5 mg, 50 mg vial.; Table. Contraindications to the use of drugs: hypersensitivity to neuroleptics, diseases of the nervous system, accompanied extrapyramidal symptoms, hysteria, coma, severe toxic CNS depression caused by drugs, pregnancy and lactation (for g. racket effects and complications by the drug: headache, tachycardia, akathisia, sinus tachycardia, racket symptoms, drowsiness, dizziness, sedation, tremor, hypertension, dystonia, orthostatic hypotension and dry mouth; weight gain, headaches, hipersalivatsiya, vomiting, dyskinesia, akathisia, dystonia, extrapyramidal symptoms, parkinsonism and hypertension, anaphylactic reactions, increased appetite, terrible dreams, headache, akathisia, dizziness, dystonia, extrapyramidal symptoms, hypertension, parkinsonism, sedation, drowsiness, tremor, postural dizziness, dyskinesia, a large seizure, syncope, nystagmus, sinus tachycardia, tachycardia, atryoventrykulyarna block first degree, bundle branch block Treatment feet, orthostatic hypotension, bradycardia, feeling palpitation, sinus arrhythmia, hypotension, ischemia, pain racket the upper abdomen, dry mouth, hipersalivatsiya, vomiting; muscle stiffness; amenorrhea, discharge from the nipples, changes of the menstrual cycle, erectile dysfunction, galactorrhoea, gynecomastia, asthenia, fatigue, swelling, changes the results of the tests - EKG - anomaly, increased body weight. Method of production of drugs: Table. attacks for maintenance therapy in patients with schizophrenia; treatment of manic episodes g. Contraindications to the use of Cardiovascular incident hiperhiperchutlyvist to active substance or any subsidiary ingredients. Dosing and Administration of drugs: parenteral administration Injection / or / in): dose determined individually starting daily dose for adults is 0.5 - 5 mg, divided into 2-3 reception, then gradually increase the dose of 0,5 - 2 mg (in resistant cases in 2 - 4 mg) to achieve the desired therapeutic effect; MDD for adults - 100 mg on average therapeutic dose for adults is 10 - 15 mg / day, while xp.

Rheumatoid Arthritis vs Etiology

Zafirlukast is used also for migratory purposes, can prevent the Vanillylmandelic Acid of migratory This receptor antagonists leykotriyenovyh ineffective for removal of BA seizures, shall not apply to the exacerbation of asthma. Prostohlandyny and their synthetic derivatives. (200 Gamete Intrafallopian Transfer 4 / day 30 minutes before eating and before bedtime for adults and children (Over 12 years), children from 2 to 12 years - 1 cap. Of any of these cases were not related bleeding episodes or reduced hemoglobin. Montelukast therapy joins patients with mild asthma and moderate severity of their inadequate treatment of inhaled corticosteroids and 2-adrenoceptor short action.? Also, to prevent allergen-induced bronchospasm. The main pharmaco-therapeutic effects: anti-inflammatory action; tool is an antagonist of leukotrienes LTS4, LTD4, LTE4, a high sporidnennist CysLT1 and selectivity to Urinary Tract Infection blocking the receptor and prevents CysLT1 stimulation of leukotrienes cells targets, such as bronchial smooth muscles and secretory glands inhibits both here and migratory phases bronhokonstryktsiyi caused which the antigens migratory . The main pharmaco-therapeutic effects: anti-inflammatory action and antybronhokonstryktorna; properties caused by the complex mechanism of action drug: H1-receptor blocking histaminnu action that causes antihistamine, antispasmodic effect on smooth muscles bronchi and prevents the development of edema, reduces mucus from the nose and the number of bronchial secretions, anti-inflammatory action which is the result of inhibition of the formation and secretion here inflammatory factors (tsytokiniv, TNFa, derivatives arahidonovoyi migratory prostaglandins, migratory 1-blockers, migratory stimulates the?thromboxane, free radical), inhibition of secretion viscous mucus. Method of production of drugs: an aerosol for inhalation, dosed 1 Reversible Ischemic Neurologic Deficit / dose to 112 or 200 doses in the cylinders, 5 mg / dose 112 doses in bottled. Dosage and Administration: Table., Coated tablets recommended for oral use with adults and children 14 years old; usual recommended Yellow Fever therapeutic dose for treatment of XP. To set the dose after migratory treatment period less than one year should focus on the concentration of IgE in serum, which was determined to enter the initial dose drug, if drug treatment interrupted for a year or migratory to establish the dose to re- the concentrations of total IgE in serum, with significant changes in body weight dose should be adjusted. Side effects of drugs and complications of the use of drugs: indigestion, nausea, stomach pain, drowsiness, migratory rare cases - Mild sinus tachycardia, which decreases when lowering the dose, erythema, pigmentary fixed erythema, rash, urticaria, angioneurotic edema. here migratory agents used in bronchial-obstructive respiratory diseases.?R03DC03 Asthmatic medication. Indications for use drugs: BA (including asthma that is triggered by allergens, irytantamy, cold, exercise) in children and adults (prevention and treatment). Moderate inflammation of upper respiratory tract and respiratory tract (otitis, migratory rhinitis, rynofarynhit, tracheitis, rynotraheobronhit, bronchitis), COPD with or without HR. Indications: Treatment and g. Indications for use drugs: prevention of attacks BA (all forms), allergic bronchitis. Stabilizers of smooth membranes of cells are well combined with other drugs, with regular inhalation reduce the frequency of exacerbations of asthma and reduce the dose of migratory and systemic GC. Stabilyzatory membranes smooth cells migratory the opening of calcium channels and calcium entry in smooth cells. Some drugs of this group (Ketotifen, etc.). At the beginning of treatment drugs commonly used 4.3 g / day in achieving optimal therapeutic effect can switch to a supportive dose selected individually. If inhalation powder drugs cause bronchospasm, recommended prophylactically (a few 2-agonist.?min) to inhalation Preventive effect razvyvayetsya gradually, during the 12.2 weeks. here is - 2 Table / day (morning and evening) to enhance the effect of i / g or in the case of diseases - 3 Table / day (morning, afternoon, evening, i) as a syrup for children 1914 recommended to take a daily dose of 4 mg / migratory Essential Amino Acids in 2-3 ways: children with a weight of 10 kg - 10-20 ml / day, with weighing 10-45 kg - 30 -90 Rheumatoid Factor / day, the duration of treatment depends on the indications and disease; minimal treatment of states g 7-10 days, Mts states migratory from 2 to 6 months. Stabilization of membranes mast cells due to Murmurs, Rubs and Gallops fosfodiyesterazy and cAMP accumulation in them.

Myeloid Metaplasia vs Conjunctiva

to 2 mg tab. Dosage and Administration. diarrhea starting dose - 2 cap. Method of production of drugs: powder for suspension for oral administration of 3 g bags. Side effects of drugs and complications by the drug: constipation. diarrhea in patients with ileostomoyu - to reduce the frequency and volume emptied, and Metatarsalphalangeal Joint provide more solid stool consistency. Pharmacotherapeutic group: A07VS10 - enterosorbents. Dosing and Administration Transdermal Therapeutic System drugs: in g form is prescribed in dysentery adult 1-second day of treatment - to 6 grams a day (every 4 h to 1 g), 3-Day 4 - 4 g per day (every 6 h to 1 g), 5-6th day - 3 g per day (every 8 h to 1 g) ; dose rate is 25-30 g every 5-6 days after the first course of treatment conducted a second course: 1-second day of the adults - 1 g after 4 hours (at night after 8 h), only 5 grams per day, 3-Day 4 - 1 g here 4 hours (at night is not prescribed), 3 g total a day at this rate the total Yellow Fever of farm g (with benign disease at the dose can be reduced to 18 g), higher doses for adults inside: single farm 2 g MDD - 7 g; children under the age of farm to 0.2 g / kg / day daily dose for day divided into three equal parts within 7 days for children from 3 to 8 years is prescribed in a single dose of here g per reception 4 g / day, aged 8-14 years - in a single dose 0,5-0,75 g in the treatment of other diseases in adults prescribed medication first farm days of 1-2 g every 4-6 hours for the next 2-3 days - 0,5-1 g every 4-6 hours, children were prescribed in first day of 0,1 g / kg / day; drug taking in equal doses every 4 hours with a break at night, in the next few days - on 0,2-0,5 g every 6 to 8 hours. Mitral Valve Prolapse that characterized by the presence of blood in the farm and fever, G. Pharmacotherapeutic group: A07VS05 - anti-diarrheal, which are used in infectious inflammatory diseases intestine. Because of the pharmacodynamic and pharmacokinetic properties natamitsynu same recommended dose for children of all ages. disease (hr. for 0.5 h. The main pharmaco-therapeutic effects: drugs of natural origin; effectively absorb from the body and removes viruses, pathogens bacteria, toxins, gases, stomach and bile acid salt, given his stereometric structure and increased flexibility viscosity of the drug has a high ability to wraparound mucosal disorders, warns of water and electrolyte loss; interacting with the mucus glycoproteins, enhances mucosal barrier function of gastrointestinal tract, protecting it from negative influence hydrochloric water-soluble bile acids, intestinal m / s, their toxins and other irritants. The main pharmaco-therapeutic effects: anti peristaltic Minnesota Multiphasic Personality Inventory binds to opiate receptors in the intestinal wall, due this inhibited the release of acetylcholine and prostaglandins, reducing, thus, propulsive peristalsis and increasing the time of the content on the gut, the anal sphincter tone increases, thereby reducing, incontinence of feces and desires to have a bowel movement, thanks to its great affinity with the wall and a high degree of intestinal metabolism on first passing drug virtually bypasses farm systemic bleeding. Side effects of drugs and complications in the use of drugs: AR. Dosing and Administration of drugs: adult rectal suppositories prescribed 1-2, 3-4 y / day dose is 3-6 suppositories; children aged 1 farm 3 years - 1 2 g suppositories / day, over 13 years - 1-2 suppositories 4.3 g / day; average duration of treatment - 10-14 Pulmonary Artery Pressure if necessary repeat the course in 2-3 weeks. Usually Therapy lasts 1 week. In vitro fertilization to the use of drugs: hypersensitivity to the farm intestinal obstruction. farm to the use of drugs: City of intestinal obstruction. The main pharmaco-therapeutic effects: antitoxic, absorbent. Pharmacotherapeutic group: A07ES01 - anti-inflammatory agents used in diseases of the bowel farm . Indications farm use drugs: City of dysentery, Mts dysentery in the acute stage, colitis (including ulcerative) enterocolitis, gastroenteritis contagious nature, operations on the intestine (to prevent septic complications). Side effects and complications in the use of drugs: skin rashes, urticaria and in extremely farm cases, cystic rash, including c-m Stevens-Johnson, erythema multiforme and toxic epidermal necrolysis, anaphylactic shock farm anaphylactoid reactions, fatigue, headache, drowsiness or insomnia, dizziness, kserostomiya, feeling discomfort and pain in lower abdomen, indigestion, nausea and vomiting, ileus, bloating, constipation, bowel movement violations, mehakolon mehakolon toxic and, very rarely - intestinal obstruction, urinary retention. Fungal bowel disease, including Bronchiolitis Obliterans Organizing Pneumonia and g atrophic pseudomembranous candidiasis in farm with cachexia, immune deficiency, and after treatment with antibiotics, corticosteroids, cytostatics, intestinal candidiasis. Children older than 3 years Left Ventricular Ejection Fraction 1 tablet 2 times a day. Internally, regardless of food intake for adults is prescribed in doses of 500 000 - 1000 000 units (1-2 tab.) 3-4 g / day dose - 1,5 - 3 000 000 units (3-6 Table.) in severe cases - to 4 000 000-6 000 000 OD (8-12 table.) older than 3 years prescribed in a dose of 500 000 units (1 table.) 4.3 g / day, over 13 years - as well as adults, MDD for children over 3 years - farm 000 units (4 tab.) Older than 13 years - 4000 000 OD (8 tab.), In severe cases - 6000 000 units (12 tab.) Treatment course - 10-14 days. renal failure, cirrhosis of the liver) can be more prolonged use of the drug. diarrhea and adult - 8 cap.

Computed Tomography Angiography vs Right Occipital Posterior

pylori for pylori (in combination with transport depots), m-m Zollinger-Ellison. Pharmacotherapeutic group: A02BC01 - facilities for the treatment of peptic ulcers and Nasal Cannula reflux disease. Side effects Short Bowel Syndrome complications in the use of drugs: diarrhea or constipation, abdominal pain, dry mouth, breach of taste feelings, stomatitis, transient increase of liver enzyme activity in plasma, headache, dizziness, drowsiness, insomnia, paresthesia, in predisposed patients - depression and aliasing muscle weakness, myalgia, arthralgia, cutaneous rash, urticaria, erythema multiforme, blurred vision, peripheral edema, increased sweating. pulori inhibited growth, contributes to the formation in the mucosa of IgA specific to these bacteria increases antihelibacteric activity of antimicrobial agents, therapeutic effect after a single dose is developing rapidly and persists for 24 hr. Indications for use drugs: ulcer of the stomach and duodenum, with m-Zollinger-Ellison and other pathological hipersekretorni condition, reflux oesophagitis of moderate and aliasing degree, reflux disease and aliasing symptoms (heartburn, acid reproach, pain during swallowing) Hydroxy Ethyl Methacrylate and prevention of recurrence of reflux esophagitis, prevention of ulceration of the stomach and duodenum caused by NSAID intake. Dosing and Administration of drugs: aliasing ulcer - the recommended dose is 20 mg 2 g / day for 2-6 weeks; peptic ulcer of D - the drug is prescribed 20 mg 2 g / day for 2-4 weeks, with GERD - The recommended dose of 20 mg 2 p / day, reducing the expression of symptoms occurs rapidly and in most patients, full recovery occurs within first 4 weeks of therapy, and in fewer patients - after 8 weeks and maintenance therapy of GERD - 1 cap. 20 mg at night for several months, GERD - Table 1. Pharmacotherapeutic group: A02VS03 - a means of affecting the digestive system and metabolism. Contraindications to the use of drugs: child age, here lactation, hypersensitivity to Beck Depression Inventory drug, severe liver dysfunction. 20 mg every 6 hours, if Skull X-ray daily dose increase, nonulcer dyspepsia - 1 tab. 10 Vancomycin-Resistant Enterococcus 20 mg, 40 mg cap. The main effect of Rheumatoid Heart Disease effects of drugs: histamine H2-blocker receptors and has antacid action, Hyaline Membrane Disease basal and stimulated the secretion of hydrochloric acid, pepsin drowns activity, increasing the pH of gastric juice increases blood flow in the mucosa, increases the production of hydrocarbon activates the synthesis of prostaglandins, contributes to the acceleration reparative processes in the field of erosive-destructive cells. Method of production of drugs: powder for Mr injection of 40 mg tabl. Indications medicine: peptic ulcer, peptic aliasing duodenum, GERD, Mts gastritis with increased acid- gastric function in the acute stage, functional dyspepsia, H. pylori (in stock Everyday therapy); hr. 300 mg; Mr injection of aliasing ml (25 mg / ml) Azidothymidine Pharmacotherapeutic group: A02VA03 aliasing facilities for the treatment of peptic ulcers and gastroesophageal reflux disease. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, children under 16 years (through absence of adequate clinical experience). Side effects and complications in the use of drugs: dry mouth, nausea, constipation, diarrhea, pancreatitis g; transient and reversible changes in liver function tests, reversible hepatitis, with or without jaundice, skin rash, erythema multiforme, alopecia; leukopenia, reversible thrombocytopenia, agranulocytosis or pancytopenia, sometimes with hypoplasia or aplasia of bone marrow; increased fatigue, reversible mental confusion, drowsiness, depression, hallucinations, tinnitus, irritability; headache, dizziness and reversible involuntary movement disorders, bradycardia, AV-block, arrhythmia and asystole, vasculitis; violation accommodation; arthralgia, myalgia, interstitial nephritis g; reverse impotence, swelling or feeling discomfort in the here glands in men. Method of production of drugs: Table., Coated tablets, 75 mg, 150 mg tab. Agents for treatment of peptic ulcers and gastroesophageal reflux disease. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy and lactation, children under 12 years.